Sodium-glucose cotransporter 2 (SGLT2) inhibitors are a class of antihyperglycemic medications that inhibit renal glucose reabsorption in the proximal convoluted renal tubule and lead to glucosuria (1-3). Here, SLC5A2 is linked to Glycosuria.